Division of Biology and Medicine
Legorreta Cancer Center
Funding Opportunities
Find current funding opportunities for cancer-related research through local and national organizations.
Funding Opportunities
Find current funding opportunities for cancer-related research through local and national organizations.
Pivot RP
Pivot-RP provides a database of global funding opportunities for researchers of all experience levels. Curate search lists and find open RFAs for your specific research interests with your Brown login.
Open RFAs
Pfizer Global Medical Grants & Partnerships (GMGP) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s GMGP competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the knowledge gaps as outlined in the specific RFP.
For all independent medical education grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct of the independent education program.
Geographic Scope: Global (US priority)
Clinical Area: ER+/HER2- metastatic Breast Cancer
Application Due Date: May 22, 2025
Unlimited funding, Rolling application
Bold ideas to help children with brain tumors can come at any time. The Pediatric Brain Tumor Foundation accepts and evaluates requests for research funding on an ongoing basis throughout the year so that researchers are able to develop these ideas into the next scientific breakthrough. There are no deadlines, and we encourage investigators to apply at their earliest convenience.
The American Cancer Society (ACS) aims to improve the lives of people with cancer and their families through advocacy, research, and patient support and to ensure everyone has an opportunity to prevent, detect, treat, and survive cancer.
The ACS invites applications for the Clinician Scientist Development Grant (CSDG) program, which supports full-time faculty members in becoming independent investigators as clinician-scientists. This grant is designed for people trained primarily as clinicians who want to maintain clinical practice and conduct cancer research.
Grants of $135,000 a year for direct costs plus 8 percent allowable indirect costs will be awarded for three to five years.
To be eligible, applicants must work at a U.S. academic institution or eligible nonprofit, have a doctoral degree, an active clinical license, and participate in clinical care, not be a current or former primary investigator (PI) of an individual mentored training grant, and have not had an R-level or equivalent grant as PI.
For complete program guidelines and application instructions, see the American Cancer Society website.
METAvivor is pleased to announce the opening of our 2025 Award Cycle. METAvivor Research and Support Inc. is a charitable organization whose mission includes funding basic, translational, and clinical research with the goal of eradicating death due to metastatic breast cancer (MBC) by relegating it to a chronic manageable disease. METAvivor’s research program was established in 2009 to specifically fund research focused on treating established breast cancer metastases to improve outcomes for stage IV metastatic breast cancer patients.
For 2025, METAvivor will be accepting letters of intent in the following categories:
Translational - $450,000 over three years, opens February 5, 2025
Early Career - $200,000 over two years, opens February 6, 2025
Quality of Life - $200,000 over two years, opens February 7, 2025
Researchers: A training Q&A will take place on Monday, February 10th at 1:00pm Eastern / 12:00pm Central. Register for the training here.
Established in 1936, the Charles A. King Trust was created to “support and promote the investigation of human disease and the alleviation of human suffering through improved treatment.” The Charles A. King Trust Postdoctoral Fellowship Program provides funding to postdoctoral fellows and mentored clinician scientists in the mid to late stages of their research training in basic and preclinical science, and clinical, health services, population health, and implementation research to help them become independent investigators in biomedical research. Through the fellowship program, grants ranging from $194,100 to $215,000 over two years, inclusive of stipend, fringe, and a $25,000 annual flexible expense allowance will be awarded. The program supports research across biomedical fields that focuses on the causes of human disease with the mission of improving treatment.
The Mark Foundation Emerging Leader Awards support innovative cancer research from the next generation of leaders. These grants are awarded to outstanding early career investigators to support high-impact, high-risk projects that are distinct from their current research portfolio. Applicants must be three to eight years from the start of an independent faculty appointment as of December 31, 2025 (i.e., the official start date of the appointment must fall within the calendar years 2017-2022).
LOI Due May 5th at 5PM ET
Applications Due by July 28th at 5PM ET
The Mark Foundation Endeavor Awards support collaborative research projects that bring together investigators with diverse areas of expertise to tackle challenges in the prevention, diagnosis, and treatment of cancer. These grants are awarded to teams of three or more investigators to generate and integrate data from diverse lines of research and transform those insights into advances for cancer patients that could not be achieved by individual efforts. A description of the teams granted Endeavor Awards in 2023 can be found here.
Award Amount: $3,000,000 over 3 years
LOI due September 3, 2025
The Damon Runyon-Rachleff Innovation Award is designed to provide support for the next generation of exceptionally creative thinkers with “high-risk/high-reward” ideas that have the potential to significantly impact our understanding of and/or approaches to the prevention, diagnosis or treatment of cancer.
The Innovation Award is specifically designed to provide funding to extraordinary early career researchers who have an innovative new idea but lack sufficient preliminary data to obtain traditional funding. It is not designed to fund incremental advances. The research supported by the award must be novel, exceptionally creative and, if successful, have the strong potential for high impact in the cancer field.
Application Deadline: July 1, 2025
The Patient-Centered Outcomes Research Institute (PCORI) intends to issue a PCORI Funding Announcement (PFA) on August 12, 2025, seeking to fund high-quality, patient-centered comparative clinical effectiveness research (CER) studies that focus on rare diseases. This preannouncement provides potential applicants additional time to identify collaborators; obtain patient and stakeholder input on potential studies; and develop responsive, high-quality proposals.
Opens: August 12, 2025
LOI Due: September 23, 2025
Application Deadline: January 13, 2026
Office of Corporate and Foundation Relations
The Office of Corporate and Foundation Relations (CFR) works with Brown faculty and administrators to foster support for the University’s mission of research and service.